Global Life Bioventure V Sarl → IMMUNIC, INC. IMUX

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 11/100

Passive Schedule 13G filer baseline
Moderate short days-to-cover (4.1 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

1 transaction

1 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 4.10

1,861,639 shares short · -10.3% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-09-16	Nagel Robert Thorvald	director	Award	25,370	$10.12	$257K

Other 13D/G Filings on IMMUNIC, INC.

Filed	Form	Filer	Stake	Shares
2023-02-24	SC	LSP V Cooperatieve U.A.	—	—	view →
2020-09-21	SC	Eckenstein-Geigy-Stiftung	—	—	view →
2020-09-04	SC	LSP V Cooperatieve U.A.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →